Contracts › 75F40124C00092
75F40124C00092: Direct 8(A) Award of 3-YEAR, Time & Materials Type Contract to Kaiva to Provide Tplc Advisory Program (TAP) for the Cdrh
Awarded to Kaiva Strategies, Llc by Food and Drug Administration (FDA).
$4.2Mobligated
$4.2Mpotential value
11 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40124C00092 |
|---|---|
| Awardee | Kaiva Strategies, Llc |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541611 Administrative Management and General Management Consulting Services |
| PSC | R707 Support- Management: Contract/Procurement/Acquisition Support |
| Place of performance | MD |
| Offers received | 1 |
| Period of performance | 10 September 2024 to 11 September 2027 |
| Potential end | 11 September 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541611 contracts · All expiring contracts · USASpending record